More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$65.27B
EPS
25.21
P/E ratio
11.6
Price to sales
0.32
Dividend yield
2.326%
Beta
0.512021
Previous close
$292.07
Today's open
$295
Day's range
$293.78 - $301
52 week range
$273.71 - $458.75
show more
CEO
Gail K. Boudreaux
Employees
97100
Headquarters
Indianapolis, IN
Exchange
New York Stock Exchange
Shares outstanding
220704667
Issue type
Common Stock
Healthcare
Medical Service Plans
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elevance Health, Inc. - ELV
NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PRNewsWire • Mar 12, 2026

Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Elevance Health, Inc. (ELV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Seeking Alpha • Mar 10, 2026

Elevance Health and National Diaper Bank Network Launch National Pilot to Address Diaper Affordability and Improve Family Health
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) and the National Diaper Bank Network (NDBN) today announced a new national pilot program designed to expand access to diapers for families with infants and young children, helping reduce financial strain while generating evidence on how meeting basic material needs can improve maternal and child health outcomes. The 12-month pilot program will provide free diapers to up to 75 families per month at 10 Welcome Rooms operated by Elevance H.
Business Wire • Mar 3, 2026

CMS plans sanctions suspending enrollment in Elevance's Medicare Advantage drug plans
The Centers for Medicare & Medicaid Services has notified Elevance Health it plans to impose sanctions that would stop the health insurer from enrolling members in its Medicare Advantage prescription drug plans, a filing showed on Monday.
Reuters • Mar 2, 2026

Elevance Health, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Elevance Health, Inc. (NYSE: ELV). The investigation focuses on whether Elevance and its executive officers complied with federal securities laws.
GlobeNewsWire • Mar 3, 2026

Elevance Health Stock Slips. CMS to Halt Enrollment in Prescription Drug Plans.
The agency plans to suspend enrollment of beneficiaries into certain Medicare Advantage plans, Elevance says.
Barrons • Mar 2, 2026

Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. C.
Business Wire • Feb 26, 2026

Elevance Health Foundation Commits $2.3 Million to New Food as Medicine Programs Across the Country
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation has awarded 22 new grants totaling more than $2.3 million to support food as medicine programs across the country. These grants will help nonprofit organizations improve access to nutritious food and advance clinical outcomes for individuals and families experiencing food and nutrition insecurity, particularly those living with diet-related chronic conditions. This latest round of funding is part of the Foundation's five-year, $150 milli.
Business Wire • Feb 24, 2026

Is the Options Market Predicting a Spike in Elevance Health Stock?
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Zacks Investment Research • Feb 2, 2026

Top 15 High-Growth Dividend Stocks For February 2026
My Top 15 dividend growth stocks for February 2026 offer a 1.52% yield, 15.48% five-year dividend growth and are about 27% undervalued.
Seeking Alpha • Feb 2, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Elevance Health Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.